SMLR
Semler Scientific·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 2
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
Significant Net Income Growth
EPS Below Expectations
Revenue Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SMLR
Semler Scientific, Inc.
A company that offers diagnostic and testing products for the treatment of chronic diseases
Healthcare Equipment and Supplies
08/09/2007
09/28/2021
NASDAQ Stock Exchange
79
12-31
Common stock
51 E Campbell Ave Suite 107-D, Campbell, CA 95008
--
Semler Scientific, Inc., was incorporated in Oregon on August 9, 2007. The Company is a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers. The company's mission is to develop, manufacture and market innovative products and services to assist its customers in the assessment and treatment of chronic diseases. The company's patented and FDA-approved product, QuantaFlo, measures arterial blood flow in the extremities to help diagnose PAD.
Earnings Call
Q2/2025
Estimate EPS-0.27
Actual EPS5.04
Estimate Revenue8.40M
Actual Revenue8.22M
Semler Scientific's Q2 2025: Contradictions Surface in Bitcoin Acquisition Strategy and Market Dynamics
Aug 04,2025 08:39
Earnings Decrypt
Earnings Decrypt
Q1/2025
Estimate EPS--
Actual EPS-6.74
Estimate Revenue--
Actual Revenue8.84M
Semler Scientific's Q1 2025: Contradictory Signals on Bitcoin Strategy, Revenue Outlook, and Business Priorities
May 20,2025 10:35
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SMLR has released its 2025 Q3 earnings. EPS was reported at 1.07, versus the expected -0.14, beating expectations. The chart below visualizes how SMLR has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SMLR has released its 2025 Q3 earnings report, with revenue of 7.49M, reflecting a YoY change of -44.56%, and net profit of 16.90M, showing a YoY change of 201.34%. The Sankey diagram below clearly presents SMLR's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
